Employer Obligations Under New York's HERO Act Extended Through February 15, 2022

Davis Wright Tremaine LLP
Contact

Davis Wright Tremaine LLP

On Saturday, January 15, 2022, the New York State Department of Health (NYSDOH) extended its designation of COVID-19 as a highly contagious communicable disease that presents a serious risk of harm to the public health through February 15, 2022. (A copy of the NYSDOH's press release can be found here.) Accordingly, all employers must continue to administer and enforce their airborne infectious disease prevention plans.

On or before February 15, 2022, the NYSDOH Commissioner will review the level of transmission of COVID-19 in the state and determine whether to continue the designation. As detailed in our prior advisories, the NYSDOL issued guidance and FAQs detailing employer obligations under the HERO Act, which were triggered on September 6, 2021, and updated its Model Airborne Infectious Disease Exposure Prevention Plan to address face coverings in fully vaccinated workplaces.

We will continue to monitor NYSDOL's promulgation of further guidance and will provide additional advisories when that guidance is issued.

[View source.]

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Davis Wright Tremaine LLP | Attorney Advertising

Written by:

Davis Wright Tremaine LLP
Contact
more
less

Davis Wright Tremaine LLP on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide

This website uses cookies to improve user experience, track anonymous site usage, store authorization tokens and permit sharing on social media networks. By continuing to browse this website you accept the use of cookies. Click here to read more about how we use cookies.